BIO FLUORESCENT TECHNOLOGIES INC
NT 10-Q, 1996-11-15
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: ESSENTIAL RESOURCES INC, NT 10-Q, 1996-11-15
Next: CHILDRENS BROADCASTING CORP, S-3/A, 1996-11-15



<PAGE>   1
                        UNITED STATES                   -----------------------
             SECURITIES AND EXCHANGE COMMISSION              OMB APPROVAL
                   Washington, D.C.  20549              -----------------------
                                                        OMB NUMBER: 3235-0058
                         FORM 12b-25                    EXPIRES:  MAY 31, 1997
                                                        Estimated average burden
                 NOTIFICATION OF LATE FILING            hours per response..2.50
                                                        ------------------------
                                                        ------------------------
                                                              SEC FILE NUMBER
                                                                 000 19693
                                                        ------------------------
                                                        ------------------------
                                                               CUSIP NUMBER
                                                                09056 K109
                                                        ------------------------
(Check One):  
[ ] Form 10-K   [ ] Form 20-F  [ ] Form 11-K  [X] Form 10-Q  [ ] Form N-SAR

    For Period Ended:           September 30, 1996
                      --------------------------------------------------------

[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR

    For the Transition Period Ended:
                                     -----------------------------------------

- ------------------------------------------------------------------------------
  Read Instruction (on back page) Before Preparing Form. Please Print or Type.
    NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS
                   VERIFIED ANY INFORMATION CONTAINED HEREIN.
- ------------------------------------------------------------------------------

If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:

- ------------------------------------------------------------------------------

                       PART I -- REGISTRANT INFORMATION

                       Bio Fluorescent Technologies, Inc.
- ------------------------------------------------------------------------------
Full Name of Registrant


- ------------------------------------------------------------------------------
Former Name if Applicable

                     7373 North Scottsdale Road, Suite D222
- ------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)

                         Scottsdale, Arizona 85253-3550
- ------------------------------------------------------------------------------
City, State and Zip Code




                       PART II -- RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following
should be completed.  (Check box if appropriate)

         [X]              (a)     The reasons described in reasonable detail in
                                  Part III of this form could not be eliminated
                                  without unreasonable effort or expense;

         [X]              (b)     The subject annual report, semi-annual
                                  report, transition report on Form 10-K, Form
                                  20-F, 11-K, Form N-SAR, or portion thereof,
                                  will be filed on or before the fifteenth
                                  calendar day following the prescribed due
                                  date; or the subject quarterly report of
                                  transition report on Form 10-Q, or portion
                                  thereof will be filed on or before the fifth
                                  calendar day following the prescribed due
                                  date; and

         [X]              (c)     The accountant's statement or other exhibit
                                  required by Rule 12b-25(c) has been attached 
                                  if applicable.

                             PART III -- NARRATIVE

The registrant is a small business filer operating with a reduced staff, and
was unable without undue financial hardship to gather the necessary information
to file the September 30, 1996, Form 10QSB by the November 14, 1996, filing
date. The registrant intends to complete and file the Form 10QSB no later than
the November 19, 1996, extension date.


                                                (ATTACH EXTRA SHEETS IF NEEDED)
<PAGE>   2

                          PART IV -- OTHER INFORMATION

(1)              Name and telephone number of person to contact in regard to
                 this notification

<TABLE>
                  <S>                                       <C>              <C>
                     Jan J. Olivier                             602               596-0269                               
                 ---------------------------------------    -----------      ------------------
                             (Name)                         (Area Code)      (Telephone Number)
</TABLE>


(2)              Have all other periodic reports required under Section 13 or
                 15(d) of the Securities Exchange Act of 1934 or Section 30 of
                 the Investment Company Act of 1940 during the preceding 12
                 months or for such shorter period that the registrant was
                 required to file such report(s) been filed?  If answer is no,
                 identify report(s).

                                                                 [X] Yes [ ] No
                 ------------------------------------------------

(3)              Is it anticipated that any significant change in results of
                 operations from the corresponding period for the last fiscal
                 year will be reflected by the earnings statements to be
                 included in the subject report or portion thereof?

                                                                 [ ] Yes [X] No

                 If so, attach an explanation of the anticipated change, both
                 narratively and quantitatively, and, if appropriate, state the
                 reasons why a reasonable estimate of the results cannot be
                 made.

- ------------------------------------------------------------------------------
                       Bio Fluorescent Technologies, Inc.
                  --------------------------------------------
                  (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.

Date                                 By:   
     ---------------------------         -------------------------------------


INSTRUCTION: The form may be signed by an executive officer of the registrant
or by any other duly authorized representative. The name and title of the
person signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority
to sign on behalf of the registrant shall be filed with the form.

- --------------------------------------------------------------------------------
                                   ATTENTION

INTENTIONAL MISSTATEMENTS OF OMISSIONS OF FACT CONSTITUTE FEDERAL CRIMINAL
                        VIOLATIONS (SEE 18 U.S.C. 1001).
- --------------------------------------------------------------------------------

                              GENERAL INSTRUCTIONS

1.      This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the
        General Rules and Regulations under the Securities Exchange Act of 1934.

2.      One signed original and four conformed copies of this form and
        amendments thereto must be completed and filed with the Securities and
        Exchange Commission, Washington, D.C. 20549, in accordance with Rule 0-3
        of the General Rules and Regulations under the Act. The information
        contained in or filed with the form will be made a matter of public
        record in the Commission files.

3.      A manually signed copy of the form and amendments thereto shall be
        filed with each national securities exchange on which any class of
        securities of the registrant is registered. 

4.      Amendments to the notifications must also be filed on form 12b-25 but
        need not restate information that has been correctly furnished. The form
        shall be clearly identified as an amended notification.

5.      Electronic Filers. This form shall not be used by electronic filers
        unable to timely file a report solely due to electronic difficulties.
        Filers unable to submit a report within the time period prescribed due
        to difficulties in electronic filing should comply with either Rule 201
        or Rule 202 of Regulation S-T (Section 232.201 or Section 232.202 of
        this chapter) or apply for an adjustment in filing date pursuant to Rule
        13(b) of Regulation S-T (Section 232.13(b) of this chapter).



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission